Tadalafil
Product Images NDC 50436-0645

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 50436-0645). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Camber1jpj (Camber1jpg)

FDA Label Image

Label Image (Lbl504360644)

Label Image (Lbl504360644)
This is a description of a medication called Tadalafil that comes in the form of film-coated tablets. Each tablet contains 5mg of Tadalafil USP, which should not be split. The entire dose should be taken and the tablets should be kept in a tight container at a controlled room temperature. The medication is manufactured by Hetero Labs Limited in India and has a serial number and lot number. The packaging insert contains dosage information, and the medication is only available with a prescription.*
FDA Label Image

Lbl504360645

Lbl504360645
This is a medication packaging for Tadalafil. The NDC number is 50436-0645-1. Each unit dose contains 4 tablets of 10mg dosage. The manufacturer appears to be "Repsckapby Unt oo Seven LLC". The rest of the text is not legible.*
FDA Label Image

Lbl504366460

Lbl504366460
This is a description of a pharmaceutical product, Tadalafil 20mg tablets. The packaging format is Unit Dose and there is a unique identifier or NDC of 50436-6460-1. The manufacturer appears to be Tordocadlor Comone Pramacti located in Py 05k and the product was repackaged by U DoseSeveon L in 17321 G. No further information is available.*
FDA Label Image

Tadalafilfigure1.jpg (Tadalafilfigure1)

Tadalafilfigure1.jpg (Tadalafilfigure1)
This appears to be a table showing the difference in standing and supine systolic and diastolic blood pressure between two groups (Tadlai minus Placebo, and Tadlal minus Placebo) in mbg. No further information or context is available.*
FDA Label Image

Tadalafilfigure2.jpg (Tadalafilfigure2)

Tadalafilfigure2.jpg (Tadalafilfigure2)
This is a listing of two medications, Tadalafil 20mg and Doxazosin 8mg, written in an unclear format. It appears that there is also a "placebo" option combined with Doxazosin 8mg. The numbers at the bottom may refer to page numbers or timestamps.*
FDA Label Image

Tadalafilfigure4.jpg (Tadalafilfigure4)

FDA Label Image

Tadalafilfigure5.jpg (Tadalafilfigure5)

FDA Label Image

Tadalfilfigure6.jpg (Tadalafilfigure6)

FDA Label Image

Tadalafilfigure7.jpg (Tadalafilfigure7)

FDA Label Image

Tadalafilfigure8 (Tadalafilfigure8)

FDA Label Image

Tadalfilfigure9.jpg (Tadalafilfigure9)

FDA Label Image

Tadalafilstructure.jpg (Tadalafilstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.